The Alaska Cancer Registry (ACR) conducted a study to identify and correct the vital status of certain cases in its database. These cases were reported as by the original reporting health care facility but were not identified as being deceased using routine death resources. Cases incorrectly reported as deceased are referred to here as "zombies," as they are the "living dead" in the registry database. Zombie cases are problematic as they contribute toward artificially high mortality rates and artificially low survival rates. They are the opposite of "immortals," a term used in the literature to indicate cases that are alive in the registry database but are actually deceased. To start the study, ACR first linked its registry database to the state mortality database, the Social Security Death Index (SSDI), and the National Death Index (NDI). ACR has 3 non-North American Association of Central Cancer Registries (NAACCR) flag fields indicating the status of the linkage with these 3 data sources. ACR was able to identify zombie candidates by selecting deceased cases that did not successfully link with any of these 3 mortality data sources. After all 3 linkages were completed, ACR identified 20 zombie candidates out of 19,590 deceased cases. ACR researched these patients in several state-specific databases and found that 14 of them were true zombies and changed their vital status to . Of the remaining 6 deceased cases, 3 died out of country, 2 died in state, and 1 died out of state. ACR recommends that other state registries consider adding these 3 non-NAACCR mortality database flag fields, as they would make searching for zombie cases fairly routine. It would also serve as a way to perform a quality control check on deceased cases that accidentally become alive again after consolidation with a new facility source record.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414203 | PMC |
Int J Gynaecol Obstet
January 2025
Department of Obstetrics and Gynaecology, Aga-Khan University of Hospital, Nairobi, Kenya.
Placenta accreta spectrum (PAS) poses a significant risk for maternal morbidity and mortality. There is a global rise in incidence of PAS in tandem with an increase in rates of cesarian section. Previous cesarian section and presence of placenta previa are two independent risk factors for development of PAS.
View Article and Find Full Text PDFArtif Organs
January 2025
Department of Anesthesiology, Critical Care Medicine and Pain Therapy, Sapienza University of Rome, Rome, Italy.
Background: Kidney transplantation (KT) is the most effective treatment for end-stage renal disease. End-ischemic hypothermic machine perfusion (EI-HMP) has emerged as a promising method for preserving grafts before transplantation. This study aimed to compare graft function recovery in KT recipients of deceased brain-death (DBD) grafts preserved with EI-HMP versus static cold storage (SCS).
View Article and Find Full Text PDFViruses
January 2025
Global Health Program, Washington State University Global Health-Kenya, Nairobi 00200, Kenya.
Human outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) are more common in Middle Eastern and Asian human populations, associated with clades A and B. In Africa, where clade C is dominant in camels, human cases are minimal. We reviewed 16 studies (n = 6198) published across seven African countries between 2012 and 2024 to assess human MERS-CoV cases.
View Article and Find Full Text PDFViruses
January 2025
Fundação Oswaldo Cruz-Fiocruz São Paulo, Ribeirão Preto 14049-900, Brazil.
Chikungunya virus infection often manifests as an acute, self-limiting febrile illness, with arthralgia and musculoskeletal symptoms being the most commonly reported. Arthralgia can persist for months or even years, and approximately 50% of cases progress to chronic conditions. However, recent outbreaks have revealed a rising number of severe cases and fatalities.
View Article and Find Full Text PDFViruses
December 2024
School of Medicine, Tzuchi University, Hualien 970, Taiwan.
Background: Psoriasis patients who are seropositive for hepatitis B surface antigen (HBsAg) or hepatitis B core antibody (HBcAb) face an elevated risk of hepatitis B virus reactivation (HBVr) when treated with cytokine inhibitors. This study aims to elucidate the risk in this population.
Methods: A retrospective chart review was conducted to assess the risk of HBVr in 73 psoriasis patients treated with cytokine inhibitors from 2013 to 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!